132 related articles for article (PubMed ID: 8893840)
1. The simulated binding of (+/-)-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]meth yl] -1H-inden-1-one hydrochloride (E2020) and related inhibitors to free and acylated acetylcholinesterases and corresponding structure-activity analyses.
Inoue A; Kawai T; Wakita M; Iimura Y; Sugimoto H; Kawakami Y
J Med Chem; 1996 Oct; 39(22):4460-70. PubMed ID: 8893840
[TBL] [Abstract][Full Text] [Related]
2. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
3. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
Szegletes T; Mallender WD; Thomas PJ; Rosenberry TL
Biochemistry; 1999 Jan; 38(1):122-33. PubMed ID: 9890890
[TBL] [Abstract][Full Text] [Related]
4. Conformers of acetylcholinesterase: a mechanism of allosteric control.
Taylor JL; Mayer RT; Himel CM
Mol Pharmacol; 1994 Jan; 45(1):74-83. PubMed ID: 8302283
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
[TBL] [Abstract][Full Text] [Related]
6. Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands.
Szegletes T; Mallender WD; Rosenberry TL
Biochemistry; 1998 Mar; 37(12):4206-16. PubMed ID: 9521743
[TBL] [Abstract][Full Text] [Related]
7. Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program.
Pang YP; Kozikowski AP
J Comput Aided Mol Des; 1994 Dec; 8(6):683-93. PubMed ID: 7738604
[TBL] [Abstract][Full Text] [Related]
8. Dynamic mechanism of E2020 binding to acetylcholinesterase: a steered molecular dynamics simulation.
Niu C; Xu Y; Xu Y; Luo X; Duan W; Silman I; Sussman JL; Zhu W; Chen K; Shen J; Jiang H
J Phys Chem B; 2005 Dec; 109(49):23730-8. PubMed ID: 16375354
[TBL] [Abstract][Full Text] [Related]
9. Binding of the neurotoxin fasciculin 2 to the acetylcholinesterase peripheral site drastically reduces the association and dissociation rate constants for N-methylacridinium binding to the active site.
Rosenberry TL; Rabl CR; Neumann E
Biochemistry; 1996 Jan; 35(3):685-90. PubMed ID: 8547248
[TBL] [Abstract][Full Text] [Related]
10. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.
Johnson JL; Cusack B; Davies MP; Fauq A; Rosenberry TL
Biochemistry; 2003 May; 42(18):5438-52. PubMed ID: 12731886
[TBL] [Abstract][Full Text] [Related]
11. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA.
Akula N; Lecanu L; Greeson J; Papadopoulos V
Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of interactions of cholinesterases with tight binding inhibitors.
Radić Z; Manetsch R; Krasiński A; Raushel J; Yamauchi J; Garcia C; Kolb H; Sharpless KB; Taylor P
Chem Biol Interact; 2005 Dec; 157-158():133-41. PubMed ID: 16289416
[TBL] [Abstract][Full Text] [Related]
13. Receptor-dependent (RD) 3D-QSAR approach of a series of benzylpiperidine inhibitors of human acetylcholinesterase (HuAChE).
Araújo JQ; de Brito MA; Hoelz LV; de Alencastro RB; Castro HC; Rodrigues CR; Albuquerque MG
Eur J Med Chem; 2011 Jan; 46(1):39-51. PubMed ID: 21074294
[TBL] [Abstract][Full Text] [Related]
14. A docking score function for estimating ligand-protein interactions: application to acetylcholinesterase inhibition.
Guo J; Hurley MM; Wright JB; Lushington GH
J Med Chem; 2004 Oct; 47(22):5492-500. PubMed ID: 15481986
[TBL] [Abstract][Full Text] [Related]
15. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.
Kryger G; Silman I; Sussman JL
Structure; 1999 Mar; 7(3):297-307. PubMed ID: 10368299
[TBL] [Abstract][Full Text] [Related]
16. Active-site gorge and buried water molecules in crystal structures of acetylcholinesterase from Torpedo californica.
Koellner G; Kryger G; Millard CB; Silman I; Sussman JL; Steiner T
J Mol Biol; 2000 Feb; 296(2):713-35. PubMed ID: 10669619
[TBL] [Abstract][Full Text] [Related]
17. The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.
Greenblatt HM; Guillou C; Guénard D; Argaman A; Botti S; Badet B; Thal C; Silman I; Sussman JL
J Am Chem Soc; 2004 Dec; 126(47):15405-11. PubMed ID: 15563167
[TBL] [Abstract][Full Text] [Related]
18. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
19. Interactions between the peripheral site and the acylation site in acetylcholinesterase.
Rosenberry TL; Johnson JL; Cusack B; Thomas JL; Emani S; Venkatasubban KS
Chem Biol Interact; 2005 Dec; 157-158():181-9. PubMed ID: 16256966
[TBL] [Abstract][Full Text] [Related]
20. The rationale for E2020 as a potent acetylcholinesterase inhibitor.
Kawakami Y; Inoue A; Kawai T; Wakita M; Sugimoto H; Hopfinger AJ
Bioorg Med Chem; 1996 Sep; 4(9):1429-46. PubMed ID: 8894101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]